Aquisição Medicamentos Exclusivos Astrazeneca – Anifrolumab e Acalabrutinib - para o ano de 2025

ID 11276441 · Portal BASE
Price
Base Price
€318,300 .00
Effective Price
€318,300 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Vila Nova de Gaia
Bidder Count
1
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Competition
1 bidder recorded
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Dates
Publication
11 Mar 2025
Celebration
24 Jan 2025
Contracting Entity
Centro Hospitalar Vila Nova de Gaia - Espinho, EPE
NIF 508142156
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
11 Mar 2025
Signing Date
24 Jan 2025
Days Late
46
Rule
A2/A3 late publication: 46 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17